Core Laboratories (CLB) Accumulated Expenses (2022 - 2026)

Core Laboratories has reported Accumulated Expenses for 5 years, with the latest figure at $22.3 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses fell 7.29% year-over-year to $22.3 million; the trailing twelve-month figure through Mar 2026 stood at $22.3 million (down 7.29% YoY), and the FY2025 full-year result was $26.5 million, up 15.82% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $22.3 million, down from $26.5 million in the prior quarter.
• The five-year high for Accumulated Expenses was $26.5 million in Q4 2025, with the low at $18.8 million in Q4 2023.
• Historically, Accumulated Expenses has averaged $22.4 million across 5 years, with a median of $22.3 million in 2026.
• Annual changes were most pronounced in 2023 — Accumulated Expenses retreated 19.8% — and 2024, when it increased 21.87%.
• Core Laboratories' Accumulated Expenses stood at $23.4 million in 2022, then dropped by 19.8% to $18.8 million in 2023, then rose by 21.87% to $22.9 million in 2024, then advanced by 15.82% to $26.5 million in 2025, then declined by 15.95% to $22.3 million in 2026.
• The last three Accumulated Expenses figures came in at $22.3 million (Q1 2026), $26.5 million (Q4 2025), and $23.4 million (Q3 2025), per Business Quant data.